Username Password
S&P 500: 1,351.68 Change: +0.14%

CADENCE PHARMACEUTICALS INC (CADX)

Overview
Price 4.22
Price Change Today 0.00 (0.00%)
P&P rating Rating: 4
Zacks Rank 3 - HOLD
Open Price $0.00
Previous Close $4.22
Daily Range $0.00 - $0.00
52-Week Range $3.41 - $0.00
Volume 0
chart
Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III products in development, including IV APAP, for the treatment of acute pain and fever, and Omigard for the prevention of catheter-related infections. The Company is committed to the fevelopment and commercialization of pharmaceuticals to meet the needs of hospitalized patients and their caregivers.
Other Resources for CADX
zacks.com
Commentary
Zacks Blog: Company News for November 18, 2011
November 18, 2011
Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III products in development, including IV APAP, for the treatment of acute pain and fever, and Omigard for the prevention of catheter-related infections. The Company is committed to the fevelopment and commercialization of pharmaceuticals to meet the needs of hospitalized patients and their caregivers.
 
Brokerage Analyst Recommendations
11 Brokerage Firms Covering CADX
 
   
Strong Buy
7
Buy
0
Hold
3
Sell
1
Strong Sell
0
Average Broker Recommendation (ABR): 1.82
 
CADX Ratings:BUY  SELL  HOLD
CADX Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

5 Buy
0 Sell
 
Top Buy Analysis
No Buy Analysis. Be the First.

Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
JoeJustJoe
99.59 12/26/11 Picks fer the last week ov 2011....ann beyond! *-) 66 12/28/11
BearMO
99.53 09/03/10 New pick: CADX 3 09/04/10
rjm77me
99.92 10/10/09 Potential buy candidates - updated with gains on Oct 14 0
Zacks_Analysts
0.00 05/18/10 Target Date for Cadence Drug - Analyst Blog 0
Zacks_Analysts
0.00 04/23/10 Cadence to Re-file Application - Analyst Blog 0
Zacks_Analysts
0.00 03/16/10 Cadence Loss Wider Than Expected - Analyst Blog 0
Zacks_Analysts
0.00 02/16/10 Setback for Cadence Pharma - Analyst Blog 0
Commentary
BUY: CADENCE PHARMACEUTICALS INC. (CADX) Rating: 4
Start Price: $3.97
Points: -1.18
Created: 11/14/2011

Comments: 0 | Comment

Recs:
 
BUY: CADENCE PHARMACEUTICALS INC. (CADX) Rating: 4
Start Price: $7.53
Points: -92.24
Created: 10/09/2008

Comments: 0 | Comment

Recs:
 
BUY: CADENCE PHARMACEUTICALS INC. (CADX) Rating: 4
Start Price: $7.53
Points: -80.93
Created: 10/08/2008

Comments: 0 | Comment

Recs:
 
BUY: CADENCE PHARMACEUTICALS INC. (CADX) Rating: 4
Start Price: $9.70
Points: -48.37
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: CADENCE PHARMACEUTICALS INC. (CADX) Rating: 4
Start Price: $12.41
Points: -57.91
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
sunlk8 99.71 BUY Three to Six Months 11/14/2011 $3.97 $4.24
(+1.19%)
+6.80% +7.98% -1.18
Enthusiastic 53.39 BUY One to Three Months 10/09/2008 $7.53 $4.24
(+1.19%)
-43.69% +48.55% -92.24
OpeningBell 43.51 BUY Three to Six Months 10/08/2008 $7.53 $4.24
(+1.19%)
-43.69% +37.23% -80.93
Chic 31.47 BUY Six Months to a Year 01/01/2008 $9.70 $4.24
(+1.19%)
-56.29% -7.92% -48.37
SAxel 27.69 BUY Six Months to a Year 01/01/2008 $12.41 $4.24
(+1.19%)
-65.83% -7.92% -57.91
Sponsored Links